- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04942392
Digital Dance for People With Parkinson's Disease During the COVID-19 Pandemic
Digital Dance for People With Parkinson's Disease During the COVID-19 Pandemic: A Feasibility Study
Dance as a treatment to support physical, cognitive and emotional functioning, has gained increased acceptance as a healthcare intervention for people with Parkinson's Disease (PD). The impact of the COVID-19 pandemic has been far reaching with devastating effects for at-risk populations. To find alternative and safe treatment delivery options during the pandemic has been of outmost importance.
This mixed-methods, feasibility study on digital for people with Parkinson's Disease aimed to investigate: (1) the feasibility and safety of a digital home-based dance intervention for people with PD; (2) change in self-reported quality of life, cognitive complaints, psychological health and fatigue; and (3) the experience of digital dance for people with PD.
Twenty-three participants partook in 10 weekly digital dance classes at home via zoom. Feasibility outcomes measures were administered at post-test. Pre-post changes in self-reported quality of life, cognitive complaints, psychological health and fatigue were measured, as well as the experience of digital dance via focus groups.
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Stockholm, Sweden
- Balettakademien
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Self-reported diagnosis of Parkinson's Disease
- Participant in Dance for PD at Balettakademien, Stockholm, Sweden
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: digital dance for PD
|
The digital dance class was held via Zoom.
The class was scheduled once a week for 60 min and consisted of 10 sessions.
A professional, certified Dance for PD and experienced dance instructor was teaching the dance class.
The dance classes followed the Dance for PD protocol yet was adjusted to fit the digital zoom format.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Feasibility outcome measures
Time Frame: Assessed at post-test
|
The following feasibility outcome measures were assessed: (a) Technical and safety issues, (b) Compliance and motivation, (c) Self-assessed improvement in physical function, wellbeing and cognitive function and (d) The importance of dance as an artistic and creative activity. Each feasibility outcome measure was assessed via a 5-point Likert scale ranging from (1=very unsatisfactory, 5=very satisfactory), (1=not motivated, 5=very motivated), (1=noticeable worsening, 5=noticeable improvement) or (1=not meaningful, 5=very meaningful). Furthermore, each feasibility outcome measure had an open-ended question connected to it in order to capture any details related that feasibility domain. Two open-ended questions regarding positive and negative aspects of digital dancing were also included. For each feasibility outcome measure, a criterion of success was developed in order to judge the the success rate of these feasibility outcome measures. |
Assessed at post-test
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Depression and anxiety
Time Frame: 12 weeks (pretest - posttest)
|
Severity of depression and anxiety symptoms measured by Hospital Anxiety Depression scale Anxiety score: 0-21 higher score indicate more anxiety Depression score: 0-21 higher score indicate more depression
|
12 weeks (pretest - posttest)
|
Quality of life (QoL) Summary index
Time Frame: 12 weeks (pretest - posttest)
|
Quality of life measured by Parkinson's Disease Questionnaire-39 (PDQ39), Summary index: 0-100 higher scores indicate more problems. Furthermore, scores on the following subscales were assessed:
|
12 weeks (pretest - posttest)
|
Quality of life (QoL) - Bodily discomfort
Time Frame: 12 weeks (pretest - posttest)
|
Quality of life measured by Parkinson's Disease Questionnaire-39 (PDQ39). Subscale: Bodily discomfort score: 0-100 higher scores indicate more problems |
12 weeks (pretest - posttest)
|
Quality of life (QoL) Communication
Time Frame: 12 weeks (pretest - posttest)
|
Quality of life measured by Parkinson's Disease Questionnaire-39 (PDQ39). Subscale: Communication score: 0-100 higher scores indicate more problems |
12 weeks (pretest - posttest)
|
Quality of life (QoL) Cognition
Time Frame: 12 weeks (pretest - posttest)
|
Quality of life measured by Parkinson's Disease Questionnaire-39 (PDQ39). Subscale:Cognition score: 0-100 higher scores indicate more problems |
12 weeks (pretest - posttest)
|
Quality of life (QoL) Social support
Time Frame: 12 weeks (pretest - posttest)
|
Quality of life measured by Parkinson's Disease Questionnaire-39 (PDQ39). Subscale: Social support score: 0-100 higher scores indicate more problems |
12 weeks (pretest - posttest)
|
Quality of life (QoL) Stigma
Time Frame: 12 weeks (pretest - posttest)
|
Quality of life measured by Parkinson's Disease Questionnaire-39 (PDQ39). Subscale: Stigma score: 0-100 higher scores indicate more problems |
12 weeks (pretest - posttest)
|
Quality of life (QoL) Emotional well being
Time Frame: 12 weeks (pretest - posttest)
|
Quality of life measured by Parkinson's Disease Questionnaire-39 (PDQ39). Subscale: Emotional well being score: 0-100 higher scores indicate more problems |
12 weeks (pretest - posttest)
|
Quality of life (QoL) Activity of Daily Living
Time Frame: 12 weeks (pretest - posttest)
|
Quality of life measured by Parkinson's Disease Questionnaire-39 (PDQ39). Subscale: Activity of Daily Living score: 0-100 higher scores indicate more problems |
12 weeks (pretest - posttest)
|
Quality of life (QoL) - Mobility
Time Frame: 12 weeks (pretest - posttest)
|
Quality of life measured by Parkinson's Disease Questionnaire-39 (PDQ39). Subscale Mobility score: 0-100 higher scores indicate more problems |
12 weeks (pretest - posttest)
|
Fatigue
Time Frame: 12 weeks (pretest - posttest)
|
Fatigue measured by Checklist Individual Strength Questionnaire (CIS).
Total score: 20-140
|
12 weeks (pretest - posttest)
|
Subjective cognitive complaints
Time Frame: 12 weeks (pretest - posttest)
|
Improvement on subjective memory complaints measured by Prospective Retrospective Memory Questionnaire (PRMQ).
Total score: 16-80 higher scores indicate more cognitive complaints prospective score: 0-100 higher scores indicate more cognitive complaints retrospective score: 0-100 higher scores indicate more cognitive complaints short term score: 0-100 higher scores indicate more cognitive complaints long term score: 0-100 higher scores indicate more cognitive complaints self cued score: 0-100 higher scores indicate more cognitive complaints environmentally cued: 0-100 higher scores indicate more cognitive complaints
|
12 weeks (pretest - posttest)
|
Mental fatigue
Time Frame: 12 weeks (pretest - posttest)
|
Two questions from the Mental Fatigue Scale were used to measure mental fatigue (item 3) and recovery (item 4).
Answers were given on a 7-point Likert scale.
|
12 weeks (pretest - posttest)
|
Experience and meaning of digital dance for people with PD
Time Frame: Assessed at post-test
|
Two focus group interviews were conducted to examine the broader experience of digital dance for people with PD.
|
Assessed at post-test
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Age
Time Frame: Assessed at pre-test
|
Demographic characteristic: age at baseline
|
Assessed at pre-test
|
Sex
Time Frame: Assessed at pre-test
|
Demographic characteristic: sex
|
Assessed at pre-test
|
Educational level
Time Frame: Assessed at pre-test
|
Demographic characteristic: educational level
|
Assessed at pre-test
|
Previous experience of dance for Parkinson's Disease
Time Frame: Assessed at pre-test
|
Demographic characteristic: previous experience of dance for PD
|
Assessed at pre-test
|
Self-evaluated health
Time Frame: Assessed a pre-test
|
Demographic characteristic: self-evaluated health
|
Assessed a pre-test
|
Disease duration
Time Frame: Assessed at pre-test
|
Demographic characteristic: self-reported year of PD diagnosis
|
Assessed at pre-test
|
Current participation in physical exercise
Time Frame: Assessed at pre-test
|
Demographic characteristic: current participation in physical exercise
|
Assessed at pre-test
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Anna S Neely, prof, Umea University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Coronavirus Infections
- Coronaviridae Infections
- Nidovirales Infections
- RNA Virus Infections
- Virus Diseases
- Infections
- Respiratory Tract Infections
- Respiratory Tract Diseases
- Pneumonia, Viral
- Pneumonia
- Lung Diseases
- Parkinsonian Disorders
- Basal Ganglia Diseases
- Movement Disorders
- Synucleinopathies
- Neurodegenerative Diseases
- COVID-19
- Parkinson Disease
Other Study ID Numbers
- 136/2019
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
ProgenaBiomeRecruitingParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
-
King's College LondonGlaxoSmithKlineCompletedParkinson Disease | Idiopathic Parkinson Disease | Parkinson Disease, PARK8United Kingdom
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
National Yang Ming UniversityUnknownEarly Onset Parkinson Disease | Early Stage Parkinson Disease
-
Michele Tagliati, MDRecruitingREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Cedars-Sinai Medical CenterEnrolling by invitationREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Mahatma Gandhi Institute of Medical SciencesCompletedStroke, Parkinson' s Disease, Neurological Impairments, Tele-rehabilitationIndia
-
Merck Sharp & Dohme LLCCompletedParkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease
-
University of DeustoCompletedPARKINSON DISEASE (Disorder)Spain
Clinical Trials on Digital dance for PD
-
University of West AtticaWorld in Harmony/Mundo en ArmoniaActive, not recruitingParkinson DiseaseGreece
-
University of West AtticaCompleted
-
National Yang Ming UniversityRecruitingQuality of Life | Breast CancerTaiwan
-
University of Illinois at ChicagoNational Institute on Aging (NIA)CompletedHealthy Aging | Chronic StrokeUnited States
-
Northwestern UniversityNot yet recruitingDepression | Anxiety | Suicidal Ideation | Nonsuicidal Self InjuryUnited States
-
University of BonnUniversity of Leeds; University College Cork; Universidade do Porto; University... and other collaboratorsNot yet recruiting
-
PfizerCompletedInterstitial Cystitis | Painful Bladder SyndromeCanada, United States, France, Denmark, Finland, Germany
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Anthem, IncUniversity of California, Irvine; HealthCore, Inc.; Apple Inc.; CareEvolution, LLCCompleted
-
Peking University First HospitalShenzhen Zeen Health Technology Co., Ltd.Not yet recruiting